Charles Matouk, MD
Professor of NeurosurgeryCards
About
Research
Overview
1. CLINICAL TRIALS
I am currently involved in the following national and international, multi-center clinical trials that are enrolling (or about to enroll) at Yale-New Haven Hospital.
Brain Aneurysms / Subarachnoid Hemorrhage
ASTROH Trial. A multi-center, phase II randomized clinical trial of continuous low-dose IV heparin therapy in coiled low-grade aneurysmal SAH patients with significant hemorrhage burden. [My role: site-PI.]
NEWTON Trial. A multi-center, phase 3 randomized, double-blinded, placebo-controlled efficacy and safety study comparing EG-1962 to standard of care oral nimodipine in adults with aneurysmal subarachnoid hemorrhage. [My role: site-PI.]
Carotid Revascularization
CONFIDENCE Trial. A prospective, multi-center, single-arm, open-label clinical study to evaluate the safety and efficacy of Roadsaver carotid stent device used in conjunction with the Nanoparasol embolic protection system for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy. [My role: site-PI.]
CREST-2. Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. [My role: sub-investigator, interventionist.]
Intracranial Hemorrhage
MISTIE-III. The purpose of this trial is to determine the safety of using a combination of minimally invasive surgery and clot lysis with rt-PA to remove intracerebral hemorrhage (ICH). [My role: site-co-PI, lead surgeon.]
2. ADVANCED IMAGING RESEARCH
My translational research is focused on advanced imaging of the critically ill neurovascular patient. Our overall aim is to improve the safety and quality of care rendered to patient's with cerebrovascular disease.
Medical Research Interests
Academic Achievements & Community Involvement
Clinical Care
Overview
When he was a medical student, Charles Matouk, MD, met a patient with rapidly progressive dementia and weakness on the right side of his body. He recalls being “astonished” when the patient’s symptoms were fully reversed within a few weeks of having an endovascular procedure in his brain to disconnect an abnormal blood vessel (a vascular malformation) that had been causing the problem. The patient was cured. This experience was so memorable to Dr. Matouk that it inspired his decision to pursue a specialty in neurovascular surgery.
Now the chief of neurovascular surgery at Yale Medicine, Dr. Matouk has expertise in brain aneurysms, vascular malformations of the brain and spinal cord, carotid occlusive disease, acute stroke syndromes and adult-onset hydrocephalus. “In medicine today, a lot of the work that doctors do is either preventative or palliative,” Dr. Matouk remarks. “However, in neurosurgery we are able to use simple, minimally invasive procedures that can actually change everything for a patient. Their disease can be cured.”
As a surgeon, Dr. Matouk focuses on treating each patient as a person. “I hope that what I can provide patients is the opportunity to tell me their story and concerns,” he says. “It’s a partnership. My fundamental role is to help patients make an informed decision that’s right for them.” To help patients understand their conditions and treatment options, Dr. Matouk likes to show them the radiology pictures of their brain, and to sketch out what will happen during the procedure. He often encourages patients to go home and think about the information presented before making a decision to proceed.
In addition to caring for patients, Dr. Matouk is an assistant professor of neurosurgery and of radiology & biomedical imaging. He conducts clinical research on advanced imaging to help determine which aneurysms and vascular malformations are higher risk and should be prioritized for treatment, and which can be watched safely overtime.
Clinical Specialties
Fact Sheets
Normal Pressure Hydrocephalus
Learn More on Yale MedicineVascular Abnormalities
Learn More on Yale MedicineVascular Surgery
Learn More on Yale MedicineHereditary Hemorrhagic Telangiectasia (HHT)
Learn More on Yale Medicine
Board Certifications
Neurological Surgery
- Certification Organization
- Royal College of Physicians & Surgeons of CANADA
- Original Certification Date
- 2009
Yale Medicine News
News & Links
News
- February 07, 2023
Daniela Renedo, MD Wins American Heart Association Stroke Basic Science Award
- September 06, 2022
Yale Neurosurgeons Implant First Endovascular Device for Hydrocephalus in North America
- November 02, 2021
Yale Investigators Link Higher Levels of Low Density Cholesterol With Decreased Risk of Subarachnoid Hemorrhage
- May 13, 2021
AAN 2021 Virtual Annual Meeting: Highlights